Foxtail Millet (Setaria Italica (L.) P. Beauv.)-Based Diet on Postprandial Glycemic Control in Adults With Obesity and Type 2 Diabetes
This 10-week randomized controlled trial evaluated the nutritional quality and dose-specific effects of foxtail millet muffins (50 and 100 g/day) alongside a low-glycemic index diet among 102 obese adults with T2DM. The study will assess changes in glycemic control, lipid profile, liver function, and anthropometric parameters to investigate the potential of foxtail millet as a functional dietary intervention for diabetes management.
研究概览
地位
详细说明
This 10-week randomized controlled trial investigated the nutritional quality and potential health benefits of foxtail millet (Setaria italica) muffins among 102 obese adults with type 2 diabetes mellitus (T2DM). Participants were randomly allocated into three groups: placebo (wheat muffin, T₀), low-dose foxtail millet muffin (50 g/day, T₁), and high-dose foxtail millet muffin (100 g/day, T₂), with all groups following a standardized low-glycemic index diet. The nutritional composition, including proximate constituents and mineral content, and sensory acceptability of the muffins were evaluated using standard AOAC procedures and a 9-point hedonic scale. Anthropometric measurements, including body weight, BMI, and other relevant parameters, were assessed alongside fasting blood glucose (FBG), glycated hemoglobin (HbA1c), lipid profile, and liver function biomarkers at baseline and after the intervention. The study aimed to determine whether daily consumption of foxtail millet-based muffins could provide a nutritionally valuable dietary option and support improvements in glycemic regulation, metabolic health, and anthropometric status among obese adults with T2DM.
研究类型
注册 (估计的)
阶段
- 不适用
联系人和位置
学习联系方式
- 姓名:SANA NOREEN, PhD
- 电话号码:03018661160
- 邮箱:SANA.NOREEN@DNSC.UOL.EDU.PK
学习地点
-
-
Punjab Province
-
Lahore、Punjab Province、巴基斯坦、54000
- Sana Noreen
-
-
参与标准
资格标准
适合学习的年龄
接受健康志愿者
有资格学习的性别
描述
Inclusion Criteria:
- People between 30 to 60 years old.
- Body Mass Index (BMI) ≥30.0 kg/m².
- Fasting blood glucose levels ≥ 7.0 mmol/L (126 mg/dL).
- Individuals having HbA1c ≥ 6.5%.
- Elevated Lipid Profile: TC > 200 mg/dL, TG > 150 mg/dL, LDL-C > 100 mg/dL, HDL-C < 40 mg/dL (men) / < 50 mg/dL (women).
- Elevated Liver Function Tests: ALT > 56 U/L, AST > 40 U/L, ALP > 147 U/L, Total Bilirubin > 1.2 mg/dL, Albumin < 3.5 g/dL.
Exclusion Criteria:
- Individuals who have a known allergy or have experienced any adverse reaction to foxtail millet or any of the ingredients used in the muffins will not be included in the study.
- Patients who are taking medications known to significantly alter glucose metabolism or gastrointestinal absorption.
- Individuals who have recently had gastric surgery or who have surgery planned during the research period.
- Presence of other severe chronic diseases (e.g., severe renal, hepatic, or cardiovascular disease, active cancer).
- Nursing or pregnant females.
学习计划
研究是如何设计的?
设计细节
- 主要用途:卫生服务研究
- 分配:随机化
- 介入模型:并行分配
- 屏蔽:单身的
武器和干预
参与者组/臂 |
干预/治疗 |
|---|---|
|
安慰剂比较:PLACEBO T0
T₀; wheat muffin |
wheat muffin |
|
实验性的:Intervention Group (T₁)
low-dose foxtail millet muffin (T₁; 50 g/day) |
low-dose foxtail millet muffin (T₁; 50 g/day) |
|
实验性的:Intervention Group (T₂)
high-dose foxtail millet muffin (T₁; 100 g/day) |
high-dose foxtail millet muffin (T₂; 100 g/day) |
研究衡量的是什么?
主要结果指标
结果测量 |
措施说明 |
大体时间 |
|---|---|---|
|
bmi
大体时间:10 weeks
|
Body mass index (BMI) was calculated as body weight (kg) divided by the square of height (m²) and expressed in kg/m². |
10 weeks
|
|
HBA1c
大体时间:10 weeks
|
Glycated hemoglobin (HbA1c) was measured to assess average blood glucose levels over the preceding 2-3 months and expressed as a percentage (%). |
10 weeks
|
次要结果测量
结果测量 |
措施说明 |
大体时间 |
|---|---|---|
|
LIPID PROFILE
大体时间:10 WEEKS
|
Lipid profile, including total cholesterol (TC), triglycerides (TG), high-density lipoprotein cholesterol (HDL-C), and low-density lipoprotein cholesterol (LDL-C), was assessed and expressed in mg/dL. |
10 WEEKS
|
合作者和调查者
出版物和有用的链接
有用的网址
研究记录日期
研究主要日期
学习开始 (估计的)
初级完成 (估计的)
研究完成 (估计的)
研究注册日期
首次提交
首先提交符合 QC 标准的
首次发布 (实际的)
研究记录更新
最后更新发布 (实际的)
上次提交的符合 QC 标准的更新
最后验证
更多信息
此信息直接从 clinicaltrials.gov 网站检索,没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求,请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改,我们的网站上也会自动更新.